Its role in cancer is still debated: PVT1 has an oncogenic potential, by stabilizing Myc protein (Tseng et al., 2014), whereas its promoter functions as a tumor suppressor DNA element that limits Myc oncogene expression and activity (Cho et al., 2018). The gene discussed is MYC; the disease is neoplasm.